Correlation Between Innovator IBD and MoonLake Immunotherapeuti

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Innovator IBD and MoonLake Immunotherapeuti at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innovator IBD and MoonLake Immunotherapeuti into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Innovator IBD 50 and MoonLake Immunotherapeutics, you can compare the effects of market volatilities on Innovator IBD and MoonLake Immunotherapeuti and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innovator IBD with a short position of MoonLake Immunotherapeuti. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innovator IBD and MoonLake Immunotherapeuti.

Diversification Opportunities for Innovator IBD and MoonLake Immunotherapeuti

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Innovator and MoonLake is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Innovator IBD 50 and MoonLake Immunotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MoonLake Immunotherapeuti and Innovator IBD is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innovator IBD 50 are associated (or correlated) with MoonLake Immunotherapeuti. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MoonLake Immunotherapeuti has no effect on the direction of Innovator IBD i.e., Innovator IBD and MoonLake Immunotherapeuti go up and down completely randomly.

Pair Corralation between Innovator IBD and MoonLake Immunotherapeuti

Given the investment horizon of 90 days Innovator IBD is expected to generate 1.22 times less return on investment than MoonLake Immunotherapeuti. But when comparing it to its historical volatility, Innovator IBD 50 is 1.51 times less risky than MoonLake Immunotherapeuti. It trades about 0.28 of its potential returns per unit of risk. MoonLake Immunotherapeutics is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest  4,670  in MoonLake Immunotherapeutics on August 26, 2024 and sell it today you would earn a total of  762.00  from holding MoonLake Immunotherapeutics or generate 16.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Innovator IBD 50  vs.  MoonLake Immunotherapeutics

 Performance 
       Timeline  
Innovator IBD 50 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Innovator IBD 50 are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Innovator IBD showed solid returns over the last few months and may actually be approaching a breakup point.
MoonLake Immunotherapeuti 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in MoonLake Immunotherapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, MoonLake Immunotherapeuti showed solid returns over the last few months and may actually be approaching a breakup point.

Innovator IBD and MoonLake Immunotherapeuti Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Innovator IBD and MoonLake Immunotherapeuti

The main advantage of trading using opposite Innovator IBD and MoonLake Immunotherapeuti positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innovator IBD position performs unexpectedly, MoonLake Immunotherapeuti can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MoonLake Immunotherapeuti will offset losses from the drop in MoonLake Immunotherapeuti's long position.
The idea behind Innovator IBD 50 and MoonLake Immunotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA